<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35466278</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4468</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Antibodies (Basel, Switzerland)</Title><ISOAbbreviation>Antibodies (Basel)</ISOAbbreviation></Journal><ArticleTitle>Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C-Can We Match the Puzzle?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">25</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antib11020025</ELocationID><Abstract><AbstractText>The newly identified strain of the Coronaviridae family called severe acute respiratory syndrome (SARS-CoV-2) recently became the most significant health threat for adults and children. Some main predictors of severe clinical course in patients with SARS-CoV-2 infection are age and concomitant health conditions. Therefore, the proper evaluation of SARS-CoV-2-specific immunity is urgently required to understand and predict the spectrum of possible clinical phenotypes and recommend vaccination options and regimens in children. Furthermore, it is critical to characterize the nature of SARS-CoV-2-specific immune responses in children following asymptomatic infection and COVID-19 and other related conditions such as multisystem inflammatory syndrome (MIS-C), para-infectious and late postinfectious consequences. Recent studies involving children revealed a variety of cytokines, T cells and antibody responses in the pathogenesis of the disease. Moreover, different clinical scenarios in children were observed-asymptomatic seroprevalence, acute SARS-CoV-2 infection, and rarely severe COVID-19 with typical cytokine storm, MIS-C, long COVID-19, etc. Therefore, to gain a better clinical view, adequate diagnostic criteria and treatment algorithms, it is essential to create a realistic picture of the immunological puzzle of SARS-CoV-2 infection in different age groups. Finally, it was demonstrated that children may exert a potent and prolonged adaptive anti-SARS-CoV-2 immune response, with significant cross-reactions against other human Corona Viruses, that might contribute to disease sparing effect in this age range. However, the immunopathology of the virus has to be elucidated first.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lazova</LastName><ForeName>Snezhina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5884-7760</Identifier><AffiliationInfo><Affiliation>Pediatric Department, University Hospital "N. I. Pirogov", 21 "General Eduard I. Totleben", Blvd., 1463 Sofia, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Care Department, Faculty of Public Health, Medical University Sofia, Bialo More, 8 Str., 1527 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimitrova</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Pediatric Department, University Hospital "N. I. Pirogov", 21 "General Eduard I. Totleben", Blvd., 1463 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hristova</LastName><ForeName>Diana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9710-1312</Identifier><AffiliationInfo><Affiliation>Department of Immunology, National Center of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzotcheva</LastName><ForeName>Iren</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pediatric Department, University Hospital "N. I. Pirogov", 21 "General Eduard I. Totleben", Blvd., 1463 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velikova</LastName><ForeName>Tsvetelina</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0593-1272</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology, University Hospital Lozenetz, Sofia University St. Kliment Ohridski, Kozyak 1 Str., 1407 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibodies (Basel)</MedlineTA><NlmUniqueID>101587489</NlmUniqueID><ISSNLinking>2073-4468</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 specific immunity</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">cell-mediated immunity</Keyword><Keyword MajorTopicYN="N">cytokine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35466278</ArticleId><ArticleId IdType="pmc">PMC9036295</ArticleId><ArticleId IdType="doi">10.3390/antib11020025</ArticleId><ArticleId IdType="pii">antib11020025</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  Novel Coronavirus Situation Dashboard.  [(accessed on 15 January 2022)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W., et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020;382:970&#x2013;971. doi: 10.1056/NEJMc2001468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001468</ArticleId><ArticleId IdType="pmc">PMC7120970</ArticleId><ArticleId IdType="pubmed">32003551</ArticleId></ArticleIdList></Reference><Reference><Citation>Graciano-Machuca O., Villegas-Rivera G., L&#xf3;pez-P&#xe9;rez I., Mac&#xed;as-Barrag&#xe1;n J., Sifuentes-Franco S. Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress. Front. Immunol. 2021;12:723654. doi: 10.3389/fimmu.2021.723654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.723654</ArticleId><ArticleId IdType="pmc">PMC8560690</ArticleId><ArticleId IdType="pubmed">34737740</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Brief Report. Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19.  [(accessed on 15 January 2022)].  Available online:  https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  MIS-C and COVID-19.  [(accessed on 15 January 2022)]; Available online:  https://www.cdc.gov/mis-c/</Citation></Reference><Reference><Citation>Royal College of Paediatrics and Child Health Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19.  [(accessed on 15 January 2022)].  Available online:  https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance.</Citation></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA. 2020;324:259&#x2013;269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones V.G., Mills M., Suarez D., Hogan C.A., Yeh D., Segal J.B., Nguyen E.L., Barsh G.R., Maskatia S., Mathew R. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr. 2020;10:537&#x2013;540. doi: 10.1542/hpeds.2020-0123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/hpeds.2020-0123</ArticleId><ArticleId IdType="pubmed">32265235</ArticleId></ArticleIdList></Reference><Reference><Citation>Anft M., Paniskaki K., Blazquez-Navarro A., Doevelaar A., Seibert F.S., Hoelzer B., Skrzypczyk S., Kohut E., Kurek J., Zapka J., et al. COVID-19 progression is potentially driven by T cell immunopathogenesis. medRxiv. 2020. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.28.20083089</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Van Paemel R., Haerynck F. Multisystem Inflammatory Syndrome in Children Related to COVID-19: A Systematic Review. Eur. J. Pediatr. 2021;180:2019&#x2013;2034. doi: 10.1007/s00431-021-03993-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03993-5</ArticleId><ArticleId IdType="pmc">PMC7890544</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley A.H. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat. Rev. Immunol. 2020;20:453&#x2013;454. doi: 10.1038/s41577-020-0367-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0367-5</ArticleId><ArticleId IdType="pmc">PMC7296515</ArticleId><ArticleId IdType="pubmed">32546853</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter M.J., Shankar-Hari M., Tibby S.M. Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview. Intensiv. Care Med. 2021;47:90&#x2013;93. doi: 10.1007/s00134-020-06273-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06273-2</ArticleId><ArticleId IdType="pmc">PMC7556601</ArticleId><ArticleId IdType="pubmed">33057783</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters P.S. The Molecular Biology of Coronaviruses. Adv. Virus Res. 2006;66:193&#x2013;292. doi: 10.1016/S0065-3527(06)66005-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(06)66005-3</ArticleId><ArticleId IdType="pmc">PMC7112330</ArticleId><ArticleId IdType="pubmed">16877062</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter M.J., Fish M., Jennings A., Doores K.J., Wellman P., Seow J., Acors S., Graham C., Timms E., Kenny J., et al. Peripheral Immunophenotypes in Children with Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection. Nat. Med. 2020;26:1701&#x2013;1707. doi: 10.1038/s41591-020-1054-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1054-6</ArticleId><ArticleId IdType="pubmed">32812012</ArticleId></ArticleIdList></Reference><Reference><Citation>Velikova T.V., Kotsev S.V., Georgiev D.S., Batselova H.M. Immunological aspects of COVID-19: What do we know? World J. Biol. Chem. 2020;11:14&#x2013;29. doi: 10.4331/wjbc.v11.i2.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.4331/wjbc.v11.i2.14</ArticleId><ArticleId IdType="pmc">PMC7520644</ArticleId><ArticleId IdType="pubmed">33024515</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomov L.P., Velikova T.V., Batselova H.M. Health Risk Management in Kindergartens, Schools and Universities, during COVID-19 Pandemic: A Heuristic Framework. Am. Int. J. Biol. Life Sci. 2021;3:40&#x2013;43. doi: 10.46545/aijbls.v3i1.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.46545/aijbls.v3i1.207</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg S.P., Connors T.J., Zhu Y., Baldwin M.R., Lin W.H., Wontakal S., Szabo P.A., Wells S.B., Dogra P., Gray J., et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 2021;22:25&#x2013;31. doi: 10.1038/s41590-020-00826-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00826-9</ArticleId><ArticleId IdType="pmc">PMC8136619</ArticleId><ArticleId IdType="pubmed">33154590</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce C.A., Preston-Hurlburt P., Dai Y., Aschner C.B., Cheshenko N., Galen B., Garforth S.J., Herrera N.G., Jangra R.K., Morano N.C., et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl. Med. 2020;12:eabd5487. doi: 10.1126/scitranslmed.abd5487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd5487</ArticleId><ArticleId IdType="pmc">PMC7658796</ArticleId><ArticleId IdType="pubmed">32958614</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosif S., Neeland M.R., Sutton P., Licciardi P.V., Sarkar S., Selva K.J., Do L., Donato C., Quan Toh Z., Higgins R., et al. Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Nat. Commun. 2020;11:5703. doi: 10.1038/s41467-020-19545-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19545-8</ArticleId><ArticleId IdType="pmc">PMC7658256</ArticleId><ArticleId IdType="pubmed">33177504</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen C.A., Li A.P., Hachim A., Hui D.S., Kwan M.Y., Tsang O.T., Chiu S.S., Chan W.H., Yau Y.S., Kavian N., et al. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat. Commun. 2021;12:4678. doi: 10.1038/s41467-021-24938-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24938-4</ArticleId><ArticleId IdType="pmc">PMC8322064</ArticleId><ArticleId IdType="pubmed">34326343</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippatos F., Tatsi E., Michos A. Immune response to SARS-CoV-2 in children: A review of the current knowledge. Pediatr. Investig. 2021;5:217&#x2013;228. doi: 10.1002/ped4.12283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ped4.12283</ArticleId><ArticleId IdType="pmc">PMC8441939</ArticleId><ArticleId IdType="pubmed">34540321</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaeigoudari A., Mollaei H.R., Arababadi M.K., Nosratabadi R. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System. Inflammation. 2021;44:2151&#x2013;2169. doi: 10.1007/s10753-021-01519-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-021-01519-7</ArticleId><ArticleId IdType="pmc">PMC8442517</ArticleId><ArticleId IdType="pubmed">34524614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasuga Y., Zhu B., Jang K.-J., Yoo J.-S. Innate immune sensing of coronavirus and viral evasion strategies. Exp. Mol. Med. 2021;53:723&#x2013;736. doi: 10.1038/s12276-021-00602-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00602-1</ArticleId><ArticleId IdType="pmc">PMC8099713</ArticleId><ArticleId IdType="pubmed">33953325</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske J., R&#xf6;hmel J., Lukassen S., Stricker S., Magalh&#xe3;es V.G., Liebig J., Chua R.L., Th&#xfc;rmann L., Messingschlager M., Seegebarth A., et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 2021;40:319&#x2013;324. doi: 10.1038/s41587-021-01037-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01037-9</ArticleId><ArticleId IdType="pubmed">34408314</ArticleId></ArticleIdList></Reference><Reference><Citation>Geurtsen J., Driessen N.N., Appelmelk B.J. Microbial Glycobiology. Elsevier; Amsterdam, The Netherlands: 2010. Mannose&#x2013;fucose recognition by DC-SIGN; pp. 673&#x2013;695.</Citation></Reference><Reference><Citation>Han D.P., Lohani M., Cho M.W. Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J. Virol. 2007;81:12029&#x2013;12039. doi: 10.1128/JVI.00315-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00315-07</ArticleId><ArticleId IdType="pmc">PMC2168787</ArticleId><ArticleId IdType="pubmed">17715238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu L. The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern to Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent Mechanism. mBio. 2016;7:e01872-15. doi: 10.1128/mBio.01872-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01872-15</ArticleId><ArticleId IdType="pmc">PMC4752600</ArticleId><ArticleId IdType="pubmed">26861016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y.-Z., Wang S.-Y., Zheng Z.-Q., Huang Y., Li W.-W., Xu Z.-S., Wang Y.-Y. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Cell. Mol. Immunol. 2021;18:613&#x2013;620. doi: 10.1038/s41423-020-00571-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00571-x</ArticleId><ArticleId IdType="pmc">PMC7588591</ArticleId><ArticleId IdType="pubmed">33110251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J.H., Wang Y.N., Chang Q.Y., Ma P., Hu Y., Cao X. Type III Interferons in Viral Infection and Antiviral Immunity. Cell Physiol. Biochem. 2018;51:173&#x2013;185. doi: 10.1159/000495172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495172</ArticleId><ArticleId IdType="pubmed">30439714</ArticleId></ArticleIdList></Reference><Reference><Citation>Vono M., Huttner A., Lemeille S., Martinez-Murillo P., Meyer B., Baggio S., Sharma S., Thiriard A., Marchant A., Godeke G.J., et al. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. Cell Rep. 2021;37:109773. doi: 10.1016/j.celrep.2021.109773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109773</ArticleId><ArticleId IdType="pmc">PMC8440231</ArticleId><ArticleId IdType="pubmed">34587479</ArticleId></ArticleIdList></Reference><Reference><Citation>Worbs T., Hammerschmidt S.I., F&#xf6;rster R. Dendritic cell migration in health and disease. Nat. Rev. Immunol. 2017;17:30&#x2013;48. doi: 10.1038/nri.2016.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.116</ArticleId><ArticleId IdType="pubmed">27890914</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A.K., Hollander G.A., McMichael A. Evolution of the immune system in humans from infancy to old age. Proc. R. Soc. B. 2015;282:20143085. doi: 10.1098/rspb.2014.3085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2014.3085</ArticleId><ArticleId IdType="pmc">PMC4707740</ArticleId><ArticleId IdType="pubmed">26702035</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselin-Paturel C., Trinchieri G. Production of type I interferons: Plasmacytoid dendritic cells and beyond. J. Exp. Med. 2005;202:461&#x2013;465. doi: 10.1084/jem.20051395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20051395</ArticleId><ArticleId IdType="pmc">PMC2212850</ArticleId><ArticleId IdType="pubmed">16103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss-Ayali D., Conrad S.M., Mosser D.M. Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 2007;82:244&#x2013;252. doi: 10.1189/jlb.0307191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0307191</ArticleId><ArticleId IdType="pubmed">17475785</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., M&#xf8;ller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181:1036&#x2013;1045.e9. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang Y., Miller L.C., Blecha F. Macrophage Polarization in Virus-Host Interactions. J. Clin. Cell Immunol. 2015;6:311. doi: 10.4172/2155-9899.1000311.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9899.1000311</ArticleId><ArticleId IdType="pmc">PMC4512304</ArticleId><ArticleId IdType="pubmed">26213635</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli C., Benincasa G., Criscuolo C., Faenza M., Liberato C., Rusciano M. Immune reactivity during COVID-19: Implications for treatment. Immunol. Lett. 2021;231:28&#x2013;34. doi: 10.1016/j.imlet.2021.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2021.01.001</ArticleId><ArticleId IdType="pmc">PMC7787505</ArticleId><ArticleId IdType="pubmed">33421440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Chu H., Hou Y., Chai Y., Shuai H., Lee A.C., Zhang X., Wang Y., Hu B., Huang X., et al. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated with Viral Antagonism of STAT1 Phosphorylation. J. Infect. Dis. 2020;222:734&#x2013;745. doi: 10.1093/infdis/jiaa356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa356</ArticleId><ArticleId IdType="pmc">PMC7337793</ArticleId><ArticleId IdType="pubmed">32563187</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutt T.S., LaVergne S.M., Webb T.L., Baxter B.A., Stromberg S., McFann K., Berry K., Tipton M., Alnachoukati O., Zier L., et al. Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease. J. Immunol. 2022;208:685&#x2013;696. doi: 10.4049/jimmunol.2100830.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100830</ArticleId><ArticleId IdType="pubmed">34987111</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreews M., Le Gouge K., Khaldi-Plassart S., Pescarmona R., Mathieu A.L., Malcus C., Djebali S., Bellomo A., Dauwalder O., Perret M., et al. Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children. Sci. Immunol. 2021;6:eabh1516. doi: 10.1126/sciimmunol.abh1516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh1516</ArticleId><ArticleId IdType="pmc">PMC8815705</ArticleId><ArticleId IdType="pubmed">34035116</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Neilan A.M., Bartsch Y., Patel A.B., Regan J., Arya P., Gootkind E., Park G., Hardcastle M., St John A., et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. J. Pediatr. 2020;227:45&#x2013;52.e45. doi: 10.1016/j.jpeds.2020.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.037</ArticleId><ArticleId IdType="pmc">PMC7438214</ArticleId><ArticleId IdType="pubmed">32827525</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce C.A., Sy S., Galen B., Goldstein D.Y., Orner E., Keller M.J., Herold K.C., Herold B.C. Natural mucosal barriers and COVID-19 in children. JCI Insight. 2021;6:e148694. doi: 10.1172/jci.insight.148694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148694</ArticleId><ArticleId IdType="pmc">PMC8262299</ArticleId><ArticleId IdType="pubmed">33822777</ArticleId></ArticleIdList></Reference><Reference><Citation>Park A., Iwasaki A. Type I and type III interferons&#x2014;Induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe. 2020;27:870&#x2013;878. doi: 10.1016/j.chom.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7255347</ArticleId><ArticleId IdType="pubmed">32464097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., P&#xe9;r&#xe9; H., Charbit B., Bondet V., Chenevier-Gobeaux C., et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718&#x2013;724. doi: 10.1126/science.abc6027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V. Autoantibodies against type I IFNsin patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., Ogishi M., Sabli I.K.D., Hodeib S., Korol C., et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella L.A., Giles J.R., Baxter A.E., Oldridge D.A., Diorio C., Kuri-Cervantes L., Alanio C., Pampena M.B., Wu J.E., Chen Z., et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci. Immunol. 2021;6:eabf7570. doi: 10.1126/sciimmunol.abf7570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abf7570</ArticleId><ArticleId IdType="pmc">PMC8128303</ArticleId><ArticleId IdType="pubmed">33653907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy A., Brodsky N.N., Sumida T.S., Comi M., Asashima H., Hoehn K.B., Li N., Liu Y., Shah A., Ravindra N.G., et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Immunity. 2021;54:1083&#x2013;1095.e7. doi: 10.1016/j.immuni.2021.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.003</ArticleId><ArticleId IdType="pmc">PMC8043654</ArticleId><ArticleId IdType="pubmed">33891889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman M. &#x201c;Superantigens&#x201d; may shed light on immune puzzle. Science. 1990;248:685&#x2013;686. doi: 10.1126/science.2333520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2333520</ArticleId><ArticleId IdType="pubmed">2333520</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogan P.A., Shah V., Klein N., Dillon M.J. V beta&#x2013;restricted T cell adherence to endothelial cells: A mechanism for superantigen-dependent vascular injury. Arthritis Rheum. 2004;50:589&#x2013;597. doi: 10.1002/art.20021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20021</ArticleId><ArticleId IdType="pubmed">14872503</ArticleId></ArticleIdList></Reference><Reference><Citation>Okarska-Napiera&#x142;a M., Ludwikowska K.M., Szenborn L., Dudek N., Mania A., Buda P., Ksi&#x105;&#x17c;yk J., Mazur-Malewska K., Figlerowicz M., Szczukocki M., et al. Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register. J. Clin. Med. 2020;9:3386. doi: 10.3390/jcm9113386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9113386</ArticleId><ArticleId IdType="pmc">PMC7690437</ArticleId><ArticleId IdType="pubmed">33105634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang A., Chorath K., Moreira A., Evans M., Burmeister-Morton F., Burmeister F., Naqvi R., Petershack M., Moreira A. COVID-19 in 7780 pediatric patients: A systematic review. eClinicalMedicine. 2020;24:100433. doi: 10.1016/j.eclinm.2020.100433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100433</ArticleId><ArticleId IdType="pmc">PMC7318942</ArticleId><ArticleId IdType="pubmed">32766542</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber C.N., Patel R.S., Trachtman R., Lepow L., Amanat F., Krammer F., Wilson K.M., Onel K., Geanon D., Tuballes K., et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C) Cell. 2020;183:982&#x2013;995.e14. doi: 10.1016/j.cell.2020.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020;183:968&#x2013;981.e7. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Schvartz A., Belot I., Kone-Paut I. Pediatric inflammatory multisystem syndrome and rheumatic diseases during SARS-CoV-2 pandemic. Front. Pediatr. 2020;8:833. doi: 10.3389/fped.2020.605807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.605807</ArticleId><ArticleId IdType="pmc">PMC7746854</ArticleId><ArticleId IdType="pubmed">33344389</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Caeseele P., Bailey D., Forgie S.E., Dingle T.C., Krajden M., Canadian Public Health Laboratory Network SARS-CoV-2 (COVID-19) serology: Implications for clinical practice, laboratory medicine and public health. CMAJ. 2020;192:E973&#x2013;E979. doi: 10.1503/cmaj.201588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.201588</ArticleId><ArticleId IdType="pmc">PMC7840513</ArticleId><ArticleId IdType="pubmed">32753391</ArticleId></ArticleIdList></Reference><Reference><Citation>Slabakova Y., Gerenska D., Ivanov N., Velikova T. Immune titers of protection against severe acute respiratory syndrome coronavirus 2: Are we there yet? Explor. Immunol. 2022;2:9&#x2013;24. doi: 10.37349/ei.2022.00033.</Citation><ArticleIdList><ArticleId IdType="doi">10.37349/ei.2022.00033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Wang X., Du R.H., Zhang W., Si H.R., Zhu Y., Shen X.R., Li Q., Li B., Men D., et al. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Emerg. Microb. Infect. 2021;10:905&#x2013;912. doi: 10.1080/22221751.2021.1919032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1919032</ArticleId><ArticleId IdType="pmc">PMC8143642</ArticleId><ArticleId IdType="pubmed">33870851</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell A.C., Butler M.S., Jinks E., Tut G., Lancaster T., Sylla P., Begum J., Bruton R., Pearce H., Verma K., et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat. Immunol. 2022;23:40&#x2013;49. doi: 10.1038/s41590-021-01089-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01089-8</ArticleId><ArticleId IdType="pmc">PMC8709786</ArticleId><ArticleId IdType="pubmed">34937928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkman R., Jebbink M.F., El Idrissi N.B., Pyrc K., M&#xfc;ller M.A., Kuijpers T.W., Zaaijer H.L., van der Hoek L. Human coronavirus NL63 and 229E seroconversion in children. J. Clin. Microbiol. 2008;46:2368&#x2013;2373. doi: 10.1128/JCM.00533-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00533-08</ArticleId><ArticleId IdType="pmc">PMC2446899</ArticleId><ArticleId IdType="pubmed">18495857</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkman R., Jebbink M.F., Gaunt E., Rossen J.W., Templeton K.E., Kuijpers T.W., van der Hoek L. The dominance of human coronavirus OC43 and NL63 infections in infants. J. Clin. Virol. 2012;53:135&#x2013;139. doi: 10.1016/j.jcv.2011.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.11.011</ArticleId><ArticleId IdType="pmc">PMC7108278</ArticleId><ArticleId IdType="pubmed">22188723</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang A.T., Garcia-Carreras B., Hitchings M., Yang B., Katzelnick L.C., Rattigan S.M., Borgert B.A., Moreno C.A., Solomon B.D., Trimmer-Smith L., et al. A systematic review of antibody-mediated immunity to coronaviruses: Kinetics, correlates of protection, and association with severity. Nat. Commun. 2020;11:4704. doi: 10.1038/s41467-020-18450-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18450-4</ArticleId><ArticleId IdType="pmc">PMC7499300</ArticleId><ArticleId IdType="pubmed">32943637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.W., Faulkner N., Cornish G.H., Rosa A., Harvey R., Hussain S., Ulferts R., Earl C., Wrobel A.G., Benton D.J., et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339&#x2013;1343. doi: 10.1126/science.abe1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1107</ArticleId><ArticleId IdType="pmc">PMC7857411</ArticleId><ArticleId IdType="pubmed">33159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus J., Grifoni A., Tarke A., Sidney J., Ramirez S.I., Dan J.M., Burger Z.C., Rawlings S.A., Smith D.M., Phillips E., et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89&#x2013;94. doi: 10.1126/science.abd3871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3871</ArticleId><ArticleId IdType="pmc">PMC7574914</ArticleId><ArticleId IdType="pubmed">32753554</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelde A., Bilich T., Heitmann J.S., Maringer Y., Salih H.R., Roerden M., L&#xfc;bke M., Bauer J., Rieth J., Wacker M., et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. 2021;22:74&#x2013;85. doi: 10.1038/s41590-020-00808-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00808-x</ArticleId><ArticleId IdType="pubmed">32999467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju B., Zhang Q., Ge J., Wang R., Sun J., Ge X., Yu J., Shan S., Zhou B., Song S., et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020;584:115&#x2013;119. doi: 10.1038/s41586-020-2380-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2380-z</ArticleId><ArticleId IdType="pubmed">32454513</ArticleId></ArticleIdList></Reference><Reference><Citation>Madera S., Crawford E., Langelier C., Tran N.K., Thornborrow E., Miller S., DeRisi J.L. Nasopharyngeal SARS-CoV-2 viral loads in young children, do not differ significantly from those in older children and adults. Sci. Rep. 2021;11:3044. doi: 10.1038/s41598-021-81934-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81934-w</ArticleId><ArticleId IdType="pmc">PMC7862672</ArticleId><ArticleId IdType="pubmed">33542262</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.M., Diorio C., Goodwin E.C., McNerney K.O., Weirick M.E., Gouma S. SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19. medRxiv. 2020. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.17.20176552</ArticleId><ArticleId IdType="pmc">PMC7799010</ArticleId><ArticleId IdType="pubmed">33263756</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Nutrition and immunity: Lessons for COVID-19. Nutr. Diabetes. 2021;11:19. doi: 10.1038/s41387-021-00165-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41387-021-00165-0</ArticleId><ArticleId IdType="pmc">PMC8223524</ArticleId><ArticleId IdType="pubmed">34168111</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Mcfarland S., Simpson F. Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID: A Survey of 510 Children. Preprints. 2021:2021030271. doi: 10.20944/preprints202103.0271.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202103.0271.v1</ArticleId><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel C.L., Lap C.R., Buddingh E.P., van Houten M.A., van der Sande L.J., Langereis E.J., Bannier M.A., Pijnenburg M.W., Hashimoto S., Terheggen-Lagro S.W. Pediatric long-COVID: An overlooked phenomenon? Pediatr. Pulmonol. 2021;56:2495&#x2013;2502. doi: 10.1002/ppul.25521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children- a nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., Zhang A.X., O&#x2019;Mahoney L.L., Stephenson T.J., Ladhani S.N., DeStavola B.L., Viner R.M., Swann O.V. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J. Infect. 2021;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle B.W., Manlhiot C. SARS-CoV-2&#x2013;related inflammatory, multisystem syndrome in children: Different or shared etiology and pathophysiology as Kawasaki disease? JAMA. 2020;324:246&#x2013;248. doi: 10.1001/jama.2020.10370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10370</ArticleId><ArticleId IdType="pubmed">32511667</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagliola G., Spada E., Consolini R. Severe COVID-19 in pediatric age: An update on the role of the anti-rheumatic agents. Pediatr. Rheumatol. 2021;19:68. doi: 10.1186/s12969-021-00559-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00559-5</ArticleId><ArticleId IdType="pmc">PMC8094984</ArticleId><ArticleId IdType="pubmed">33947420</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt R.A., Paschold L., Rivas M.N., Cheng M.H., Yonker L.M., Chandnani H., Lopez M., Simnica D., Schulthei&#xdf; C., Santiskulvong C., et al. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J. Clin. Investig. 2021;131:e146614. doi: 10.1172/JCI146614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI146614</ArticleId><ArticleId IdType="pmc">PMC8121516</ArticleId><ArticleId IdType="pubmed">33705359</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>